单克隆胰岛素自身免疫综合征成功用血细胞定向疗法治疗
Frida Bugge Askeland1, Hege M Frøen2, Nils Bolstad3
1Department of Haematology, Oslo Myeloma Center, Oslo University Hospital, Nydalen, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Blindern, Oslo, Norway.
Clinical lymphoma, myeloma & leukemia
|November 5, 2024
概括
血细胞导向疗法为单克隆胰岛素自身免疫综合征 (IAS) 提供了一种安全有效的治疗方法,这种罕见的疾病会导致严重的低血糖症. 这种方法导致了两个患有这种自身免疫性疾病的患者的缓解.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 单克隆胰岛素自身免疫综合征 (IAS) 是一种罕见的自身免疫疾病.
- 它的特征是严重的低血糖,由于由B细胞克隆产生的抗胰岛素抗体,通常是克隆性血细胞.
研究的目的:
- 评估血细胞定向治疗在单克隆性IAS患者中的疗效和安全性.
- 报告两个用血细胞定向疗法治疗的单克隆IAS病例.
主要方法:
- 两个挪威女性患者单克隆性IAS的案例介绍.
- 抗胰岛素抗体的量化和表征使用免疫沉和手动内部测定.
- 用血细胞导向疗法进行治疗.
主要成果:
- 这两位患者都实现了临床缓解.
- 第一个患者接受了有限时间的治疗,在没有可检测的抗体的情况下持续缓解.
- 第二位患者,在持续治疗中,表现为缓解,抗体水平较低.
结论:
- 血细胞定向治疗对于单克隆性IAS是有效和安全的.
- 这种治疗方法推用于被诊断为单克隆性IAS的患者.
相关概念视频
01:31Hybridoma Technology
14.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.2K
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:29Autoimmune Disorders
398
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
398